(2E)-1-(3-methoxyphenyl)-3-(5-methylfuran-2-yl)prop-2-en-1-one, 95.0%, 10g

N-(9-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 1g

1-Stearoyl-sn-glycero-3-phosphocholine>98.0%(HPLC)(T)250mg

5-Bromo-2-methoxypyridine>98.0%(GC)(T)5g

4-fluorobenzenesulfonohydrazide, 5g

Benzyl 4-Hydroxybenzoate>98.0%(GC)(T)25g

6-(Benzyloxy)-1H-indazole, 95.0%, 5g

6-BROMO-N,N-BIS(4-METHOXYBENZYL)-4-METHYL-5-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE, 95%, 100mg

(4S,4'S)-1,1'-Bis(3-(tert-butyl)phenyl)-4,4'-diisobutyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 250mg

4-(2,2,2-Trifluoroethoxy)pyridine-2-carboxylic acid, 1g

2-(3-(Benzyloxy)-6-bromo-2-fluorophenyl)-1,3-dioxolane, 98%, 5g

Sanguinarine nitrate, min. 95%, 10 mg, glass packaging

2-Bromo-5-(difluoromethyl)thiophene, 95%, 10g